NOS2 and graft versus host disease: Interestingly, wild-type MSCs have been shown to block graft-versus-host disease (GVHD) and delayed-type hypersensitivity in lethally-irradiated recipient mice but not IFNγR1−/− or iNOS−/− MSCs.